(Q73011012)

English

Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B. European Concerted Action on Viral Hepatitis (Eurohep)

scientific article published on 01 December 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

0 references

Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B. European Concerted Action on Viral Hepatitis (Eurohep) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

viral hepatitis

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

E Christensen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

N Bindslev

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Schalm

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P K Andersen

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Ring-Larsen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 December 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Journal of Hepatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

795-802

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of 28 consecutive days lymphoblastoid interferon (alpha-IFN) administration on hepatitis B virus related chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoblastoid interferon therapy of chronic HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariate survival analysis using Cox's regression model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing response to interferon in chronic hepatitis B: Implications for Asian and western populations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980281-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(96)80281-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007705%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73011012&oldid=2154946068"